PRKAA/AMPKα phosphorylation switches the role of RASAL2 from a suppressor to an activator of autophagy

Yong Bao1,2, Christopher Qian3, Meng-Yue Liu1

  • 1Institute of Translational and Precision Medicine, Nantong University, Nantong, China.

Autophagy
|February 10, 2021
PubMed

Insights

RASAL2 regulates autophagy by controlling AMPK phosphorylation. Its S351 phosphorylation promotes breast tumor growth, suggesting therapeutic targeting for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • RASAL2 (RAS protein activator like 2) is a RAS GTPase activating protein that inactivates the RAS pathway in cancer.
  • The precise cellular functions of RASAL2 are not fully understood.
  • Autophagy, a cellular degradation process, plays a complex role in cancer development and progression.

Purpose of the Study:

  • To elucidate the role of RASAL2 in regulating autophagy.
  • To investigate the mechanism by which RASAL2 influences autophagy initiation and promotion.
  • To determine the clinical significance of RASAL2 phosphorylation in breast cancer.

Main Methods:

  • Investigated RASAL2's interaction with protein phosphatase PPM1B/pp2cβ.
  • Examined the effect of glucose starvation on RASAL2 and PRKAA/AMPKα.
  • Analyzed the phosphorylation status of RASAL2 at S351 and its impact on the PIK3C3/VPS34 complex.
  • Correlated RASAL2 S351 phosphorylation with clinical outcomes in breast cancer patients.

Main Results:

  • RASAL2 inhibits basal autophagy under normal conditions by recruiting PPM1B/pp2cβ to attenuate PRKAA/AMPKα phosphorylation.
  • Glucose starvation triggers dissociation of PPM1B/pp2cβ from RASAL2, leading to PRKAA/AMPKα-mediated phosphorylation of RASAL2 at S351.
  • Phosphorylated RASAL2 enhances PIK3C3/VPS34 activity and promotes autophagy.
  • RASAL2 S351 phosphorylation is linked to increased breast tumor growth and poorer clinical outcomes in breast cancer patients.

Conclusions:

  • RASAL2 acts as a molecular switch controlling AMPK-mediated autophagy through its S351 phosphorylation status.
  • RASAL2 phosphorylation can either suppress or promote autophagy, influencing cancer progression.
  • Targeting RASAL2 S351 phosphorylation may offer a therapeutic strategy to overcome resistance to AMPK-activation agents in cancer therapy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K